Oral corticosteroid use in Swedish and Finnish severe asthma patients

K. Geale (Stockholm, Sweden), H. Darabi (Stockholm, Sweden), M. Lindh (Stockholm, Sweden), L. Alvares (Basel, Switzerland), R. Dodge (Copenhagen, Denmark), A. Altraja (Tartu, Estonia), V. Backer (Copenhagen, Denmark), L. Bjermer (Lund, Sweden), A. Bossios (Stockholm, Sweden), C. Janson (Uppsala, Sweden), H. Kankaanranta (Seinäjoki, Finland), P. Kauppi (Helsinki, Finland), L. Lehtimäki (Tampere, Finland), C. Suppli Ulrik (Copenhagen, Denmark), A. Viinanen (Turku, Finland), C. Porsbjerg (Copenhagen, Denmark)

Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Session: Asthma treatment: cohorts and real-world studies
Session type: Thematic Poster
Number: 2564
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Geale (Stockholm, Sweden), H. Darabi (Stockholm, Sweden), M. Lindh (Stockholm, Sweden), L. Alvares (Basel, Switzerland), R. Dodge (Copenhagen, Denmark), A. Altraja (Tartu, Estonia), V. Backer (Copenhagen, Denmark), L. Bjermer (Lund, Sweden), A. Bossios (Stockholm, Sweden), C. Janson (Uppsala, Sweden), H. Kankaanranta (Seinäjoki, Finland), P. Kauppi (Helsinki, Finland), L. Lehtimäki (Tampere, Finland), C. Suppli Ulrik (Copenhagen, Denmark), A. Viinanen (Turku, Finland), C. Porsbjerg (Copenhagen, Denmark). Oral corticosteroid use in Swedish and Finnish severe asthma patients. 2564

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019



Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018


Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry.
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Antibiotics use for asthma exacerbation in Japanese geriatric patients
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Oral corticosteroid prescription in asthma: Swiss situation
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020


Oral corticosteroids-related comorbidities in severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021

The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010

Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020


Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Oral montelukast in patients with acute severe asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007


Impact of omalizumab in patients with severe asthma
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

BTS Difficult Asthma Registry: Effect of omalizumab dosing table expansion on size of population of severe persistent allergic asthma patients potentially eligible for omalizumab therapy
Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma
Year: 2012

Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016
Source: Eur Respir J, 53 (4) 1802130; 10.1183/13993003.02130-2018
Year: 2019



Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013

Efficacy of montelukast in Indian patients having chronic persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003

Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020
Year: 2021



Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007


Genome-wide association study of asthma symptoms despite inhaled corticosteroids use in Dutch children.
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017

Asthma control among patients receiving inhaled corticosteroids in general practice in Thailand
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010


Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002